82 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
exclusivity ü up to 20 years of 25% federal tax credit for expenses the U.S. ü waiver of Prescription Drug User Fee Act (PDUFA) fees, a value https
8-K
EX-4.2
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense … transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
(bb) Tax Status. Except for matters that would … or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any
8-K
EX-4.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall … , the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required
8-K
EX-4.1
crnp9eq
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
v8vid ymwwgj
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
slxdz1tyygnbq
13 Mar 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
x70e lv670flf
6 Mar 24
Other Events
8:00am
424B5
nkm2 xtaq
14 Feb 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-1.1
l8f4hd475j 5pqiwm
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-4.2
yizxejev3u yq
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-4.1
hi28s66na 6go20
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-10.1
9vemljp5n3 98chiw9m
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
424B5
fjdoghuw
17 Nov 23
Prospectus supplement for primary offering
9:06am
8-K
EX-4.1
b8t k78pl1
16 Nov 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
17my 8ow0m8pm
13 Nov 23
Other Events
6:07am